The German Research Foundation funds 3 graduate schools at TU Dresden

November 14, 2016

The German Research Foundation has announced the funding of three Graduate Schools at TU Dresden. On Nov. 11 it has approved the applications from the schools of civil engineering, medicine and computer science.

New Graduate School (GRK) 2250: New construction and strengthening of concrete structures under impact loadings
The central goal of the Graduate School with about 25 scientists is to make existing buildings and structures considerably more resilient through the application of flat, thin-layered reinforcements. The impetus is the elevated danger of short-term dynamic loads e.g. during natural disasters or detonations.

New Graduate School (GRK) 2251: Immunological and Cellular Strategies in Metabolic Disease
The main goal of the research is an improved understanding of pathologically altered body functions with type 1 diabetes (T1D) and type 2 diabetes (T2D). Regenerative and interventional strategies are to be developed in order to halt the progression of the disease or even find a cure.

Continuation: Graduate School 1763 - Quantitative Logics and Automata
The focus is on the exhaustive exploration of quantitative logics and their applicability in computer science, e.g. for modelling of hardware and software systems
-end-
Media Inquiries:
GRK 2250 - Civil Engineering
Prof. Viktor Mechtcherine
Tel. +49 351 463-36311
E-Mail: Mechtcherine@tu-dresden.de

GRK 2251 - Medicine
Prof. Andreas Birkenfeld/ Prof. Stefan Bornstein
Tel. +49 351 458-3651
E-Mail: andreas.birkenfeld@uniklinikum-dresden.de

GRK 1763 - Computer Science
Prof. Franz Baader
Tel. +49 351 463-39160
E-Mail: franz.baader@tu-dresden.de

Technische Universität Dresden

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.